Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
Clinical trial NCT04070443 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04070443
- Sponsor
- Centre Leon Berard
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2029-06-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.